About
Imaging Products, Antibodies
Areas of Focus
Categories
DiagnosticsRadiopharmaceuticalsAntibodySan Diego & Southern California
Clinical Trials (13)
View allTotal Trials
13
As Lead Sponsor
7
As Collaborator
6
Total Enrollment
253
By Phase
PHASE2/PHASE3: 1PHASE2: 5PHASE1/PHASE2: 2EARLY_PHASE1: 1PHASE1: 3
By Status
COMPLETED: 6TERMINATED: 3WITHDRAWN: 2NOT_YET_RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06218069Collaborator
Immuno-pet IMaging ResPonses AdministeRed Immune CheckpoiNt InhibiTor
PHASE2/PHASE3Not yet recruiting
20 participants
Started: Feb 28, 2025 · Completed: Mar 31, 2027
NCT05744128Lead Sponsor
CD8 Minibody Repeatability Study
PHASE2Terminated
3 participants
Started: Feb 16, 2023 · Completed: May 31, 2024
NCT05397171Collaborator
A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours
PHASE1/PHASE2Terminated
17 participants
Started: Jun 7, 2022 · Completed: Jun 6, 2023
NCT05279027Collaborator
Zr89 + PET Companion Trial
EARLY_PHASE1Completed
6 participants
Started: Mar 8, 2022 · Completed: May 6, 2025
NCT04874818Collaborator
CD8+ T-cell PET/CT Imaging in COVID-19 Patients
N/ATerminated
5 participants
Started: Feb 14, 2022 · Completed: Dec 31, 2022
Locations (1)
Headquarters
Inglewood, CA, United States
Map
Loading map...